Conference abstract
Conference abstractPublished 27 Jul 2015
Transcription-based chronobiology of receptor tyrosine kinases: Relevance to cancer progression
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Tumor-specific combinations of oncogenic mutations often free cancer cells from their reliance on growth factors. One important example comprises the epidermal growth factor receptor (EGFR) and its kin, HER2. In tumors, both EGFR and HER2 frequently display overexpression, internal deletions and point mutations. Accordingly, monoclonal antibodies and kinase inhibitors specific to these receptors have been approved for clinical application. The lecture will introduce efforts to resolve the logic underlying gene expression programs activated by growth factors and relationships to tumor progression. Wavelike induction of defined groups of transcripts follows receptor activation, and a similar pattern is displayed by microRNAs. Interestingly, the earliest event we detect is a concerted downregulation of microRNAs that collectively suppress the earliest wave of up-regulated genes, a group of transcription factors that includes FOS and JUN. Importantly, the waves of mRNAs and microRNAs are reflected in breast and other tumors, implying that growth factors play vital roles in tumor progression. The lecture will focus on two emerging features of gene expression programs, which are initiated by activated receptors for growth factors. The first feature is a seemingly pulsatile mode of signals that regulates cell cycle progression. Accordingly, commitment to S-phase entry depends on a fruitful second pulse of signaling, which removes inhibition by the wild type form of p53. The other feature relates to an apparent diurnal regulation of growth factor signaling. This requires signaling by steroid hormones and entails a crosstalk between nuclear receptors and receptor tyrosine kinases, such as EGFR. The implications of both pulsatile regulation of transcription and its diurnal control will be discussed in the context of tumor progression.
Subjects
Genetics & Molecular BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 2020
Dynamic Changes of EGFR Activating Mutations as an Early Predictor of Progression in Non–Small Cell Lung Cancer Patients Treated with EGFR Tyrosine Kinase Inhibitors
Research article · 5 Jun 2020
Dynamic Changes of EGFR Activating Mutations as an Early Predictor of Progression in NonâÂ?Â?Small Cell Lung Cancer Patients Treated with EGFR Tyrosine Kinase Inhibitors
Conference abstract · 2017
Investigation of LRRC24, a putative negative regulator of ErbB receptor tyrosine kinases
Case report · 30 Dec 2024
Tyrosine Kinase Receptors: Mechanisms, Functions, and Therapeutic Implications
More from this journal
The newest in Transcriptomics: Open Access.
Commentary · 30 Dec 2025
Transcriptomic Biomarkers for Early Diagnosis and Prognosis of Diseases
Commentary · 30 Dec 2025
Metatranscriptomics for Understanding Microbial Community Functionality
Commentary · 30 Dec 2025
Single-Nucleus Transcriptomics in Neurological Disorder Research
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalTranscriptomics: Open Access
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “Yosef Yarden”

